e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
254.31
+0.96 (+0.38%)
Official Closing Price
Updated: 4:10 PM EDT, Jun 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,358,464
Open
253.05
Bid (Size)
253.59 (100)
Ask (Size)
255.40 (400)
Prev. Close
253.35
Today's Range
249.20 - 255.99
52wk Range
181.75 - 253.35
Shares Outstanding
N/A
Dividend Yield
2.72%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 No-Brainer Dividend Stocks to Buy Right Now
↗
Today 12:03 EDT
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
↗
Today 11:41 EDT
In the past five years, this top healthcare stock has risen by close to 130%.
Via
The Motley Fool
Performance
YTD
+10.9%
+10.9%
1 Month
+16.8%
+16.8%
3 Month
+19.3%
+19.3%
6 Month
+10.2%
+10.2%
1 Year
+37.0%
+37.0%
More News
Read More
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
Today 0:32 EDT
Via
StockStory
Topics
Retirement
Stocks
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
↗
June 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Inc (NYSE:ABBV) Breakout Setup Combines Strong Technical Rating with High-Quality Consolidation Entry
↗
June 17, 2026
Via
Chartmill
Is AbbVie a Buy After Its Purchase of Apogee?
↗
June 25, 2026
Via
The Motley Fool
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
↗
June 24, 2026
Via
Benzinga
2 Value Stocks Worth Your Attention and 1 Facing Headwinds
June 24, 2026
Via
StockStory
3 Monster Stocks to Hold for the Next 10 Years
↗
June 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
Why AbbVie Stock Jumped Today
↗
June 22, 2026
Via
The Motley Fool
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?
↗
June 22, 2026
Via
The Motley Fool
Monday's session: top gainers and losers in the S&P500 index
↗
June 22, 2026
Via
Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
June 22, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
Explore the top gainers and losers within the S&P500 index in today's session.
↗
June 22, 2026
Via
Chartmill
5 Dividend Stocks to Buy and Hold Forever
↗
June 22, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Excellent Dividend Stocks to Buy on the Dip
↗
June 22, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Profitable Stocks Worth Your Attention and 1 We Avoid
June 22, 2026
Via
StockStory
How Many Botox Units Do You Need: Forehead, Crow's Feet, and Frown Lines
June 18, 2026
Via
Press Release Distribution Service
3 High-Yield Dividend Stocks to Buy Hand Over Fist in June
↗
June 15, 2026
Via
The Motley Fool
Topics
Economy
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?
↗
June 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.
↗
June 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
↗
June 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
Stocks
The Best Stocks to Invest $500 in Right Now
↗
June 04, 2026
Via
The Motley Fool
Dry eye syndrome drugs Market Size, Industry Report By 2035
↗
June 04, 2026
Via
Talk Markets
Topics
Economy
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 254.31
When was AbbVie last traded?
The last trade of AbbVie was at 06/29/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.